Guide — Sleep Medicine
Obstructive Sleep Apnea: Pathophysiology & Management
OSA is the most common sleep-related breathing disorder, defined by repetitive collapse of the upper airway during sleep despite continued respiratory effort. This guide covers the mechanism, risk factors, AHI severity thresholds, STOP-BANG screening, polysomnography diagnosis, and the PAP-first management approach that respiratory therapists implement and support.
11 min read · Sleep Medicine
Written by Apex Respiratory Editorial Team
Educational use only. This material supports respiratory therapy education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional protocols, or physician orders. Always follow facility policies and current provider orders, and verify calculations independently before clinical use.
Overview
Obstructive sleep apnea occurs when the pharynx repeatedly collapses during sleep despite the diaphragm and chest wall continuing to generate respiratory effort. The fundamental distinction from central apnea is this persistence of effort: chest and abdomen move in paradoxical opposition (thoraco-abdominal asynchrony) while no air flows past the obstruction.
The mechanism hinges on pharyngeal muscle tone. During wakefulness the genioglossus and other pharyngeal dilators contract with each breath to counteract the tendency of a narrow or crowded airway to collapse under the negative pressure of inspiration. Sleep reduces that tonic activity — dramatically so during REM sleep — and if the airway is anatomically crowded, negative inspiratory pressure overwhelms the remaining dilator force and the lumen closes.
Each obstructive event produces intermittent hypoxemia (SpO₂ desaturation with the characteristic sawtooth pattern on PSG), transient hypercapnia, and a cortical arousal that restores muscle tone and reopens the airway — usually without full awakening. Hundreds of these micro-arousals per night fragment sleep architecture and generate the daytime consequences that bring patients to clinical attention.
Key Concepts
Risk Factors
- Obesity— especially central and neck adiposity; neck circumference > 43 cm (17 in) in men or > 40 cm (16 in) in women increases risk substantially.
- Demographics— male sex, increasing age, and postmenopausal status.
- Craniofacial anatomy— retrognathia, craniofacial crowding, enlarged tonsils or adenoids, and nasal obstruction all narrow the pharyngeal space.
- Substances & conditions — alcohol and sedatives near bedtime, hypothyroidism, and family history.
Symptoms
Loud habitual snoring, witnessed apneas or gasping/choking arousals, and excessive daytime sleepiness (EDS) are the cardinal triad. Additional symptoms include nonrestorative sleep, morning headaches, nocturia, mood and cognitive impairment, and decreased libido. The Epworth Sleepiness Scale(0–24) is a validated patient-reported measure; a score > 10 suggests clinically significant EDS.
AHI Severity Classification
| Severity | AHI (events/hour) | Clinical Notes |
|---|---|---|
| Normal | < 5 events/hour | No OSA diagnosis |
| Mild OSA | 5 to < 15 events/hour | Diagnosis requires symptoms or comorbidities at this range |
| Moderate OSA | 15 to < 30 events/hour | CPAP typically indicated |
| Severe OSA | ≥ 30 events/hour | CPAP strongly indicated; high cardiovascular risk |
STOP-BANG Screening Tool
STOP-BANG is the most widely validated pre-test screening questionnaire. Score 0–2 = low risk; 3–4 = intermediate risk; ≥ 5 = high risk for moderate-to-severe OSA. Other validated tools include the STOP, Berlin Questionnaire, and Epworth Sleepiness Scale.
| Letter | Item | Question / Criterion |
|---|---|---|
| S | Snoring | Do you snore loudly? |
| T | Tired | Do you often feel tired or sleepy during the day? |
| O | Observed apnea | Has anyone observed you stop breathing during sleep? |
| P | Pressure | Do you have or are you being treated for high blood pressure? |
| B | BMI > 35 kg/m² | Body mass index above 35 |
| A | Age > 50 | Older than 50 years |
| N | Neck > 40 cm | Neck circumference greater than 40 cm |
| G | Gender male | Male sex |
Consequences of Untreated OSA
Untreated OSA carries significant systemic risk. Recurrent hypoxemia and sympathetic activation drive systemic hypertension — OSA is the most common identifiable cause of resistant hypertension. Additional consequences include pulmonary hypertension, atrial fibrillation and other arrhythmias, increased risk of myocardial infarction and stroke, insulin resistance and metabolic syndrome, and motor-vehicle accidents attributable to excessive daytime sleepiness.
Assessment & Findings
Diagnosis requires objective testing. In-lab attended polysomnography (PSG) is the gold standard. It simultaneously records sleep staging (EEG, EOG, chin EMG), airflow, respiratory effort (chest and abdominal belts), SpO₂, ECG, leg movements, and body position. OSA is confirmed at AHI ≥ 5 with symptoms or relevant comorbidities, or AHI ≥ 15 regardless of symptoms.
Home sleep apnea testing (HSAT) is an acceptable alternative for uncomplicated adult patients with a high pretest probability of moderate-to-severe OSA. HSAT measures airflow, respiratory effort, and SpO₂ without sleep staging, so it tends to underestimate AHI. A negative or low-AHI HSAT in a symptomatic high-probability patient is not a true negative — it warrants follow-up with in-lab PSG.
Key PSG pattern in OSA
- Repetitive obstructive events (absent airflow WITH persistent thoraco-abdominal effort)
- Sawtooth SpO₂ desaturations, worst during REM sleep and in the supine position
- Cortical arousals following each event, fragmenting sleep architecture
- Daytime ABG is usually normal in pure OSA — daytime hypercapnia (PaCO₂ ≥ 45 mm Hg) is a red flag for obesity hypoventilation syndrome (OHS) or overlap syndrome, not isolated OSA
RT Priorities & Interventions
- PAP therapy is first-line for moderate-to-severe OSA. CPAP works by pneumatically splinting the pharynx open throughout the respiratory cycle. The RT’s role spans titration (in-lab or auto-PAP), mask selection and fitting, humidification optimization, and ongoing adherence troubleshooting — poor adherence, most often driven by mask leak, is the primary reason CPAP fails.
- Patient education— explain the mechanism, expected benefits (reduced sleepiness, lower cardiovascular risk), how to clean equipment, and what to expect in the first weeks. Insurance compliance thresholds (≥ 4 hours/night on ≥ 70% of nights in a 30-day period) should be reviewed with the patient.
- Behavioral adjuncts— weight loss reduces AHI proportionally in obese patients; positional therapy (avoiding supine sleep) helps position-dependent OSA; eliminating alcohol and sedatives near bedtime reduces event frequency.
- Alternative therapies— mandibular advancement devices (MADs) are appropriate for mild-to-moderate OSA or CPAP-intolerant patients. Surgical options (uvulopalatopharyngoplasty, hypoglossal nerve stimulation) are reserved for selected cases after multidisciplinary evaluation.
- Perioperative caution— OSA should be identified and addressed before elective surgery. Opioids and sedatives blunt arousal responses and worsen obstruction; communicate active OSA status to the anesthesia team and continue PAP therapy postoperatively.
Common Pitfalls
- Confusing OSA with central apnea. Obstructive apnea = no airflow WITH continued respiratory effort (paradoxical thoraco-abdominal motion). Central apnea = no airflow AND no effort. The distinction is clinically and therapeutically important.
- Assuming all snorers have OSA — or missing OSA in non-obese patients. Snoring alone is not diagnostic. Conversely, lean patients with craniofacial crowding or retrognathia can have severe OSA and are sometimes overlooked because they “don’t look like” a typical OSA patient.
- Attributing CPAP failure to the patient rather than the mask. Poor mask fit causes leak, pressure loss, and arousals — the most common cause of non-adherence. Mask refitting or switching interface type (nasal, nasal pillow, full-face) resolves many “CPAP-intolerant” cases.
- Missing daytime hypercapnia as a red flag. Pure OSA does not cause daytime CO₂ retention. If the daytime ABG shows PaCO₂ ≥ 45 mm Hg, consider OHS (Pickwickian syndrome) or COPD-OSA overlap syndrome, both of which alter management.
- Over-trusting a negative HSAT. HSAT can underestimate AHI (no sleep staging, positional shifts unmonitored). A negative HSAT in a symptomatic, high-pretest-probability patient is not reassuring — proceed to in-lab PSG.
Board Exam Pearls
- Obstructive apnea definition: no airflow WITH continued effort — chest and abdomen move paradoxically. Central apnea = no airflow AND no effort.
- AHI cutoffs to memorize: 5 (diagnosis threshold with symptoms) / 15 (diagnosis regardless of symptoms) / 30 (severe). Mild 5–<15 / Moderate 15–<30 / Severe ≥ 30.
- CPAP is first-line for moderate-to-severe OSA. Oral appliance = mild-to-moderate or CPAP intolerance.
- Worse in REM and supine. REM reduces pharyngeal muscle tone the most; supine position allows tongue to fall posteriorly — both worsen obstructive events.
- Cardiovascular consequences: resistant hypertension, atrial fibrillation, pulmonary hypertension. OSA is the leading correctable cause of resistant HTN — a high-yield exam association.
- Daytime hypercapnia ≠ pure OSA. Elevated PaCO₂ on a daytime ABG points to OHS or overlap syndrome — pure OSA produces normal daytime gases.
FAQ
Is obstructive sleep apnea the same as snoring?
No. Snoring is airway vibration; OSA is repetitive airway collapse causing apneas and hypopneas with oxygen desaturation and cortical arousals. Most people who snore do not have OSA, but loud habitual snoring with witnessed apneas is a red flag that warrants formal evaluation.
What AHI means a person has OSA?
An apnea-hypopnea index of 5 or more events per hour with symptoms or comorbidities, or 15 or more events per hour regardless of symptoms. AHI 5 to less than 15 is mild, 15 to less than 30 is moderate, and 30 or more is severe.
Does everyone with OSA need CPAP?
CPAP is first-line for moderate-to-severe disease. Mild OSA may be managed with weight loss, positional therapy, or a mandibular advancement device. Patients who cannot tolerate CPAP have alternatives, including oral appliances and, in selected cases, surgical options such as hypoglossal nerve stimulation.
Can you have OSA without being obese?
Yes. Craniofacial features such as retrognathia, enlarged tonsils, nasal obstruction, male sex, and advancing age all contribute to pharyngeal crowding independent of weight. Normal-weight patients can have significant OSA, so screening should not be limited to obese individuals.
Screen for daytime hypoventilation
Pure OSA produces normal daytime ABGs. If you suspect obesity hypoventilation syndrome or COPD–OSA overlap, run the ABG interpreter to classify the acid-base pattern and identify daytime hypercapnia (PaCO₂ ≥ 45 mm Hg) or hypoxemia that would change management.
Open the ABG Interpreter →Related Resources
Sources
- Kacmarek RM, Stoller JK, Heuer AJ. Egan's Fundamentals of Respiratory Care. 12th ed. Elsevier; 2021.
- Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263-276.
- Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479-504.